• ABPI Website
  • Publications
  • Ensuring best practice in the notifications of product discontinuation: Best practice guidelines

Ensuring best practice in the notifications of product discontinuation: Best practice guidelines

Ensuring best practice in the notifications of product discontinuation: Best practice guidelines

Publication date:

Publication size: 0.32 MB

Download

Discontinuing a medicine is a decision that most pharmaceutical companies will take at some point.

The Department of Health and the ABPI want to ensure that the impact of such a decision on patients is minimised and therefore we have worked together – and with industry representatives and healthcare professionals – to produce these good practice guidelines.

Last modified: 20 September 2023

Last reviewed: 20 September 2023